(Q48483969)

11 February 2018

title

Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III. (English)

1 reference

11 February 2018

1 reference

1 reference

Rudolf A Kristof

1

1 reference

11 February 2018

Georg Neuloh

2

1 reference

11 February 2018

Volkmar Hans

3

1 reference

11 February 2018

Martina Deckert

4

1 reference

11 February 2018

Horst Urbach

5

1 reference

11 February 2018

Uwe Schlegel

6

1 reference

11 February 2018

Matthias Simon

7

1 reference

11 February 2018

Johannes Schramm

8

1 reference

11 February 2018

publication date

1 September 2002

1 reference

11 February 2018

Journal of Neuro-Oncology

published in

1 reference

11 February 2018

volume

59

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

231-237

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1019987116596

exact match

0 references

cites work

Oligodendrogliomas: the Mayo Clinic experience

1 reference

12 December 2020

Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.

1 reference

12 December 2020

The treatment of anaplastic oligodendrogliomas and mixed gliomas.

1 reference

12 December 2020

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

A clinicopathological study of 323 patients with oligodendrogliomas.

1 reference

12 December 2020

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

1 reference

12 December 2020

The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study.

1 reference

12 December 2020

Successful chemotherapy for recurrent malignant oligodendroglioma

1 reference

12 December 2020

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

1 reference

12 December 2020

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

1 reference

12 December 2020

A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.

1 reference

12 December 2020

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

12 December 2020

Acute leukemia following treatment of malignant glioma

1 reference

12 December 2020

Combined treatment modality for anaplastic oligodendroglioma: a phase II study.

1 reference

12 December 2020

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

12 December 2020

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

1 reference

12 December 2020

Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma.

1 reference

12 December 2020

Power and sample size calculations. A review and computer program

1 reference

12 December 2020

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1019987116596

1 reference

11 February 2018

Dimensions Publication ID

1011103667

0 references

1 reference

11 February 2018